共 248 条
[1]
De Caterina R(2007)n-3 fatty acids in the treatment of diabetic patients: biological rationale and clinical data Diabetes Care 30 1012-1026
[2]
Madonna R(2008)Erythrocyte fatty acid composition and the metabolic syndrome: a national heart, lung, and blood institute GOLDN study Clin Chem 54 154-162
[3]
Bertolotto A(2011)Associations of obesity with triglycerides and C-reactive protein are attenuated in adults with high red blood cell eicosapentaenoic and docosahexaenoic acids Eur J Clin Nutr 65 808-817
[4]
Schmidt EB(2010)Increased consumption of fatty and lean fish reduces serum C-reactive protein concentrations but not inflammation markers in feces and in colonic biopsies J Nutr 140 371-376
[5]
Kabagambe EK(2011)Effects of prescription omega-3-acid ethyl esters on fasting lipid profile in subjects with primary hypercholesterolemia J Cardiovasc Pharmacol 57 489-494
[6]
Tsai MY(2010)Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat diet-induced obese mice via modulation of adipose tissue inflammation J Nutr 140 1915-1922
[7]
Hopkins PN(2006)Diet and lifestyle recommendations revision 2006: a scientific statement from the American heart association nutrition committee Circulation 114 82-96
[8]
Ordovas JM(2010)Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease N Engl J Med 363 1341-1350
[9]
Peacock JM(2012)Is there any consensus as to what diet or lifestyle approach is the right one for NAFLD patients? J Gastrointestin Liver Dis 21 293-302
[10]
Borecki IB(2006)Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study Aliment Pharmacol Ther 23 1143-1151